Oraya Therapeutics Raises $42 Million
Oraya Therapeutics Inc., a Newark, Calif.-based developer of radiosurgical treatments for eye diseases, has raised $42 million in Series C funding. Domain Associates and Scale Venture Partners co-led the round, and was joined by return backers Essex Woodlands Health Ventures and Synergy Life Partners. The company previously raised $22 million.
20 July 2009•3 mins read
